Aristides Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,431
Closed -$170K 272
2021
Q4
$170K Buy
+1,431
New +$170K 0.08% 194